prof. MUDr. Miroslav Penka, CSc.
Department of Internal Medicine, Hematology and Oncology
Phone: | +420 532 23 3941 |
---|---|
E‑mail: |
Total number of publications: 430
2024
-
Factor IX activity measurement of recombinant FIX Fc fusion protein eftrenonacog alfa with one-stage clotting and chromogenic substrate assay
Year: 2024, type: Conference abstract
-
Oxidative stress, microparticles, and E-selectin do not depend on HIV suppression
Biomedical Papers, Olomouc: Palacky University, year: 2024, volume: 168, edition: 2, DOI
2023
-
Analýza imunomodulačních lymfocytů u Ph1- myeloproliferativních onemocnění pomocí průtokové cytometrie
Year: 2023, type: Appeared in Conference without Proceedings
-
Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)
Annals of hematology, year: 2023, volume: 102, edition: 11, DOI
-
Flow cytometry assesment of regulatory lymphocytes in myeloprolifeartive disorders.
Year: 2023, type: Conference abstract
-
JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, year: 2023, volume: 84, edition: 4, DOI
-
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma
Journal of clinical oncology, year: 2023, volume: 41, edition: 7, DOI
2022
-
Analysis of von Willebrand Disease in the “Heart of Europe”
TH open: companion journal to thrombosis and haemostasis, year: 2022, volume: 2022, edition: 06, DOI
-
Immature Granulocyte Count by the Sysmex XN-Series Haematology Analyser compared to the Sysmex DI-60 Digital Morphology Analyser and to Manual Microscopy
Year: 2022, type: Appeared in Conference without Proceedings
-
Neočekávaný průběh anti Xa aktivity po suicidálním požití rivaroxabanu u staršího nemocného
Geriatrie a gerontologie, year: 2022, volume: 11, edition: 2